Skip to content

Vitamin D lowered some PCOS markers, while other comparisons were inconclusive

A meta-analysis found lower insulin-resistance, inflammation, and testosterone measures with vitamin D than placebo, without clear differences in several other laboratory markers.

By 100HP editorialAbstract-based explanation checked

Based on the published abstract. The full paper may contain additional methods, results and limitations.

The 30-second takeaway

Vitamin D was linked to lower values for an insulin-resistance index, fasting insulin, an inflammatory marker, and total testosterone in patients with PCOS. Several other measurements showed no statistically significant differences. These results concern laboratory markers; the abstract does not establish improvements in symptoms, fertility, or longer-term health, and it does not identify an optimal dose.

Keep in mind

The abstract does not report participant totals, treatment duration, doses, or study-level bias assessments. This abstract-based summary therefore cannot establish how clinically meaningful or dependable the marker changes are.

THE NUMBERS, WITH CONTEXT

What researchers found

MD -0.47 (95% CI -0.66 to -0.28)

Insulin-resistance index (HOMA-IR)

Mean difference for vitamin D versus placebo; treatment duration not reported in the abstract.

Medicine (Baltimore), 2026 · Original source ↓

What the studies measured

The review pooled treatment studies focused on hormonal, metabolic, and inflammatory measurements. Its reported outcomes describe changes in measured indicators, rather than whether participants felt better or experienced fewer clinical complications.

Several comparisons were inconclusive

Fasting glucose, blood lipids, and several other hormone measures did not show statistically significant differences. That limits claims of broad metabolic improvement, but it does not prove that vitamin D has no effect on those outcomes.

CHECK THE ORIGINAL

The original publication

A meta-analysis of the effects of vitamin D supplementation on endocrine metabolic and inflammatory markers in patients with polycystic ovarian syndrome.

Wu B, Yao J
Medicine (Baltimore) · 2026

PubMed ID
41496027
Record checked

AI-assisted research and writing. This explains one selected publication; it is not a complete review of everything known. Our approach.